Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP injection for oligospermia and sperm DNA fragmentation
IRCT20220317054318N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2023
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of platelet-rich plasma in oligoasthenoteratospermia (OAT) and male infertility (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Sperm analysis and Sperm DNA fragmentation index. Started Feb 2023; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
oligoasthenoteratospermia (OAT)male infertility
Beyond the preview
Go deeper on IRCT20220317054318N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220317054318N2.